HomeMIST • NASDAQ
Milestone Pharmaceuticals Inc
add
$1.74
5.45%
Pre-market:(2.30%)-0.040
$1.70
Closed: Jun 6, 4:06:59 AM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 20.52M | 95.90% |
Net income | -20.76M | -100.51% |
Net profit margin | — | — |
Earnings per share | -0.31 | -47.62% |
EBITDA | -20.50M | -96.17% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 55.96M | -37.46% |
Total assets | 61.89M | -35.54% |
Total liabilities | 68.01M | 21.27% |
Total equity | -6.12M | — |
Shares outstanding | 66.37M | — |
Price to book | -18.33 | — |
Return on assets | -74.69% | — |
Return on capital | -87.40% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -20.76M | -100.51% |
Cash from operations | -13.95M | -56.17% |
Cash from investing | 33.58M | 224.32% |
Cash from financing | 140.00K | -99.57% |
Net change in cash | 19.77M | 644.81% |
Free cash flow | -7.36M | -22.06% |
Previous close
$1.65
Day range
$1.64 - $1.76
Year range
$0.63 - $2.75
Market cap
93.03M USD
Avg Volume
1.19M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2003
Website
Employees
33
